We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $824M
1-Year Est. Return 78.19%
This Fund
S&P 500
This Quarter Est. Return
+14.81%
1 Year Est. Return
+78.19%
3 Year Est. Return
+156.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+388.18%
AUM
$410M
AUM Growth
+$32.8M
Cap. Flow
-$16.9M
Cap. Flow %
-4.11%
Top 10 Hldgs %
40.83%
Holding
122
New
21
Increased
22
Reduced
44
Closed
13

Top Buys

Rank Stock Value
1
TMP icon
Tompkins Financial
TMP
+$4.16M
2
AGX icon
Argan
AGX
+$3.97M
3
MDU icon
MDU Resources
MDU
+$3.14M
4
AGR
Avangrid, Inc.
AGR
+$2.94M
5
OGE icon
OGE Energy
OGE
+$2.8M

Top Sells

Rank Stock Value
1
EMR icon
Emerson Electric
EMR
+$8.58M
2
BNS icon
Scotiabank
BNS
+$5.36M
3
GLW icon
Corning
GLW
+$5.06M
4
GVA icon
Granite Construction
GVA
+$5.01M
5
XOM icon
ExxonMobil
XOM
+$2.84M

Sector Composition

Rank Sector Weight
1 Healthcare 36.18%
2 Technology 23.21%
3 Industrials 21.08%
4 Utilities 8.25%
5 Communication Services 4.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EMR icon
1
Emerson Electric
EMR
$86.6B
$26.9M 6.56%
433,545
-151,074
-26% -$8.58M
BMY icon
2
Bristol-Myers Squibb
BMY
$136B
$24.1M 5.88%
409,790
-693
-0.2% -$41.5K
PFE icon
3
Pfizer
PFE
$159B
$17.6M 4.3%
567,430
+1,887
+0.3% +$64.1K
GLW icon
4
Corning
GLW
$128B
$17.2M 4.19%
662,578
-223,385
-25% -$5.06M
GSK icon
5
GSK
GSK
$102B
$16.9M 4.13%
331,920
-9,220
-3% -$473K
INTC icon
6
Intel
INTC
$473B
$14.4M 3.51%
240,452
-6,166
-3% -$369K
NVS icon
7
Novartis
NVS
$292B
$13.3M 3.25%
152,485
-350
-0.2% -$30.2K
JNJ icon
8
Johnson & Johnson
JNJ
$646B
$13M 3.17%
92,416
-268
-0.3% -$39.1K
MMM icon
9
3M
MMM
$89.9B
$12.3M 3.01%
94,482
-2,212
-2% -$279K
OGE icon
10
OGE Energy
OGE
$9.45B
$11.6M 2.84%
382,808
+90,550
+31% +$2.8M
LGTY
11
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$11.6M 2.82%
733,340
-5,233
-0.7% -$88K
MDU icon
12
MDU Resources
MDU
$4.16B
$11.5M 2.82%
1,367,998
+377,415
+38% +$3.14M
AGX icon
13
Argan
AGX
$5.86B
$11.2M 2.74%
237,149
+103,874
+78% +$3.97M
IBM icon
14
IBM
IBM
$222B
$10.9M 2.67%
94,642
+19,952
+27% +$2.32M
BCE icon
15
BCE
BCE
$21.9B
$10.8M 2.64%
258,815
+11,988
+5% +$493K
XRAY icon
16
Dentsply Sirona
XRAY
$2.22B
$9.97M 2.43%
226,350
+15,350
+7% +$649K
MSFT icon
17
Microsoft
MSFT
$3.81T
$8.91M 2.17%
43,785
+303
+0.7% +$55K
TMO icon
18
Thermo Fisher Scientific
TMO
$230B
$8.35M 2.04%
23,054
-150
-0.6% -$50.3K
LNN icon
19
Lindsay Corp
LNN
$1.16B
$8.03M 1.96%
87,057
-200
-0.2% -$18.3K
ABT icon
20
Abbott
ABT
$195B
$7.85M 1.92%
85,879
-32
-0% -$2.89K
TEL icon
21
TE Connectivity
TEL
$58.7B
$6.58M 1.61%
80,700
+4,700
+6% +$354K
MRK icon
22
Merck
MRK
$366B
$6.3M 1.54%
85,453
-401
-0.5% -$30.2K
ADM icon
23
Archer Daniels Midland
ADM
$39.3B
$6.19M 1.51%
155,250
-100
-0.1% -$3.74K
LITE icon
24
Lumentum
LITE
$80.3B
$5.75M 1.4%
70,678
-1,700
-2% -$130K
HON icon
25
Honeywell
HON
$68.9B
$5.7M 1.39%
41,804
-637
-2% -$84.3K
1
2 3 4 5

Similar funds

SWIG
Strategic Wealth Investment Group Louisville, Kentucky $825M AUM 11.63% 1-Year Est. Return
RP
Rice Partnership Honolulu, Hawaii $824M AUM 40.45% 1-Year Est. Return
WRPWM
Werba Rubin Papier Wealth Management San Jose, California $824M AUM 24.76% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $823M AUM 36.99% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $826M AUM 47.87% 1-Year Est. Return
MGAM
McGowan Group Asset Management Dallas, Texas $823M AUM 27.48% 1-Year Est. Return
HVIA
Hudson Valley Investment Advisors Goshen, New York $823M AUM 31.4% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $826M AUM 21.35% 1-Year Est. Return

John G. Ullman & Associates's Q2 2020 Portfolio in Review

As of Q2 2020, John G. Ullman & Associates held 122 positions worth $410M, up 8.7% from $377M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

John G. Ullman & Associates withdrew a net $16.9M in Q2 2020, closing 13 positions and reducing 44 holdings. Its most notable exit was Scotiabank, an estimated $5.36M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.

Against the trend, John G. Ullman & Associates opened a new position in Tompkins Financial worth $4.13M.

  • John G. Ullman & Associates's largest Q2 2020 buy was Tompkins Financial: 63,735 shares worth $4.13M.
  • John G. Ullman & Associates added most to Argan in Q2 2020, an estimated $3.97M increase.
  • John G. Ullman & Associates's biggest Q2 2020 reduction was Emerson Electric, cutting an estimated $8.58M.
  • John G. Ullman & Associates fully exited Scotiabank in Q2 2020, selling an estimated $5.36M.
  • John G. Ullman & Associates's ten largest holdings make up 41% of its $410M portfolio in Q2 2020.
  • John G. Ullman & Associates opened 21 new positions and closed 13 in Q2 2020.
  • John G. Ullman & Associates's portfolio value rose 8.7% quarter-over-quarter to $410M.

Based on John G. Ullman & Associates's 13F filing for Q2 2020, filed 29 Jul 2020.